|
SAMD8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.179310E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.524400E-03 |
| Normal-vs-Stage2 |
9.036500E-04 |
| Normal-vs-Stage3 |
1.282640E-03 |
| Normal-vs-Stage4 |
1.856180E-03 |
| Stage1-vs-Stage2 |
2.102000E-01 |
| Stage1-vs-Stage3 |
3.005000E-01 |
| Stage1-vs-Stage4 |
3.309400E-01 |
| Stage2-vs-Stage3 |
6.429200E-01 |
| Stage2-vs-Stage4 |
7.820400E-01 |
| Stage3-vs-Stage4 |
8.621800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.862600E-03 |
| Normal-vs-AfricanAmerican |
3.761800E-01 |
| Normal-vs-Asian |
2.016100E-04 |
| Caucasian-vs-AfricanAmerican |
2.533400E-01 |
| Caucasian-vs-Asian |
1.028810E-01 |
| AfricanAmerican-vs-Asian |
3.798200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.46609999999814E-05 |
| Normal-vs-Female |
6.640500E-03 |
| Male-vs-Female |
2.792300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.318500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.979900E-04 |
| Normal-vs-Age(61-80Yrs) |
5.816900E-04 |
| Normal-vs-Age(81-100Yrs) |
4.873800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.980400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.498300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.348400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.803200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.536200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.543000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.320960E-01 |
| Classical-VS-Follicular |
1.564250E-03 |
| Classical-VS-Other |
1.444240E-01 |
| Classical-VS-Normal |
2.612400E-02 |
| Tall-VS-Follicular |
5.966200E-01 |
| Tall-VS-Other |
4.156000E-01 |
| Tall-VS-Normal |
2.580300E-03 |
| Follicular-VS-Other |
6.691000E-01 |
| Follicular-VS-Normal |
2.24339999999046E-05 |
| Other-VS-Normal |
1.318430E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.11119999999898E-05 |
| Normal-vs-N1 |
1.934350E-02 |
| N0-vs-N1 |
4.401400E-01 |
|
|
